Many retroviruses, including the human and simian immunodeficiency viruses, contain a leucine zipper-like repeat in a highly conserved region of the external domain of the transmembrane (TM) glycoprotein. This region has been postulated to play a role in stabilizing the oligomeric form of these molecules. To determine what role this region might play in envelope structure and function, several mutations were engineered into the middle isoleucine of the leucine zipper-like repeat of the human immunodeficiency virus type 1 (HIV-1) TM 
The leucine zipper motif was originally described for several DNA-binding proteins. It is characterized by a heptad of amino acids consisting of a leucine residue followed by six other amino acids which is repeated several times (20, 23) . In addition, hydrophobic amino acids are found at the first and fourth residues of the heptads throughout the region, characteristic of coiled-coil structures. The sequences are predicted by computer modeling to form alpha helices, and this structure has been confirmed, using biochemical methods in some cases (29, 30, 34) . It has been shown that the motif is responsible for the dimerization of DNA-binding proteins necessary for them to bind to DNA. Mutational analyses that support an important role for the heptad repeats of leucine residues in the leucine zipper have been performed (20, 33) . Nonconservative changes at the leucine residues interfered with dimerization and resulted in the inability of the proteins to bind to DNA (20, 33) . In addition, these studies found that isoleucine and in some cases valine residues could be substituted for the leucine residues without detectable effects on dimerization or function (20, 23) .
A motif with many of the characteristics of the leucine zipper was recently identified in the membrane-spanning transmembrane protein of paramyxoviruses (1) and in the (TM) glycoprotein of many retroviruses (2, 7, 16) . The human immunodeficiency viruses (HIVs) contain a highly conserved leucine zipper-like repeat that is found throughout very diverse isolates of HIV-1 as well as simian immunodeficiency virus (SIV) and HIV-2 (Fig. 1A) . Moreover, the heptad repeat of leucine or isoleucine residues is particularly conserved and this region has been predicted, by using computer algorithms, to form an alpha helix (16) . Many membrane-spanning proteins are known to be arranged on * Corresponding author.
the surface of the cell in oligomeric structures consisting of homomultimers of the protein. Several viral glycoproteins are well studied in this regard. These include the hemagglutinin (HA) and neuraminidase glycoproteins of influenza virus (4, 17, 39, 42, 47) , the G protein of vesicular stomatitis virus (22) , the envelope glycoproteins of Rous sarcoma virus (RSV), a prototype retrovirus (10) , and HIV (8, 40) . The oligomerization of viral glycoproteins appears to be necessary for the proper transport of the glycoprotein through the secretory pathway and presumably maintains the complex in a transport-competent conformation (for a review, see ref- erence 11) . Mutations that affect oligomerization can block the transport of the glycoprotein from the endoplasmic reticulum (10, 17, 22) .
Retroviruses are enveloped viruses that bud from the plasma membrane of infected cells. During the budding process, virions obtain the viral envelope glycoproteins which have been inserted into the outer cell membrane. These glycoproteins are encoded by the env gene and synthesized as a precursor molecule that is intracellularly cleaved by host cell enzymes into the TM protein and surface attachment subunit (SU). The TM protein anchors the glycoprotein to the surface of the virion and provides the fusion function by way of an N-terminal fusion peptide (15) . The SU protein contains the receptor binding activity of the glycoprotein complex. In the case of HIV-1, the glycoprotein is synthesized as a precursor molecule, gpl60, that is cleaved to the SU protein, gp120, and the TM protein, gp4l. Studies of virus-producing cells and of cells expressing the env gene product from a variety of expression vectors have shown the HIV-1 glycoprotein to be an oligomeric structure (8, 31, 38, 40) . However, the exact nature of the glycoprotein complex is unknown, and some question remains as to whether the complex is a trimer or a tetramer, although the bulk of the data favors the latter.
The HA protein of influenza virus, for which the three- dimensional structure is known (47) , and the glycoproteins of HIV have many similar domains and functions. These features include similar organization of hydrophobic regions, cleavage/activation domains, and fusion peptides (16) . The three-dimensional structure of the HA trimer shows that the individual subunits interact with each other through a long alpha helix in HA2, the transmembrane component of the HA complex. On the basis of their similar structural features, it has been postulated that retroviral TM proteins can be modeled after the HA2 molecule of influenza virus (16) . If this is done with the HIV-1 TM glycoprotein, the putative leucine zipper region described above will lie along a region predicted to form a long alpha-helical domain analogous to that of HA2. Furthermore, studies with the RSV and HIV env gene products indicate that the external domain of the TM protein plays a critical role in oligomerization (16) . Thus, the leucine zipper region of the TM protein may interact with adjacent subunits to stabilize the oligomeric structure of the glycoprotein complex in a manner similar to the stabilization of DNA-binding proteins.
To analyze the role of the conserved region, we have mutated the proposed leucine zipper region by focusing on the middle isoleucine of the 35-amino-acid repeat, since this residue is conserved in 29 of 29 HIV-1 isolates (28) . Individual changes were made by using site-directed mutagenesis to create both conservative and nonconservative mutations at this position (Fig. 1B) . Our HeLa-T4 fusion assay. HeLa-T4 cells were plated in 35-mm-diameter dishes (Costar) and transfected with 1 ,ug of pSRHP DNA, using DEAE-dextran. Two days after transfection, the cells were stained by the May-Grunwald-Giemsa technique. Briefly, the cells were washed with PBS, then 1 ml of May-Grunwald stain (0.25% in methanol) was added, and the plates were incubated for 10 min. An equal volume of distilled water was added to each plate, and after an additional 10-min incubation, the stain was removed and Giemsa stain (1/25 dilution of a 0.4% stock) was added for 30 min before the plates were washed with distilled water.
Internal immunofluorescent staining of HeLa-T4 cells. HeLa-T4 cells were transfected by using DEAE-dextran; 48 h posttransfection, the cells were fixed in 95% ethanol-5% acetic acid (at -20°C), washed with PBS, and then incubated with a 1:20 dilution of monoclonal antibody 9284 at 4°C for 30 min. Cells were then washed with cold PBS and counterstained as described above.
Infectivity assays on H9 cells. COS-1 cells in 25-cm2 flasks were transfected with S ,ug of plasmid pHXB2Dgpt containing either a wild-type or mutant env gene. Two days after transfection, supernatants were assayed for reverse transcriptase activity as described below. Supernatants were adjusted to equivalent reverse transcriptase values with Dulbecco modified Eagle medium, and 1.0 ml of supematant was added to 1.0 ml of medium containing 3 x 10 H9 cells in a 15-ml conical tube. After incubation at 37°C for 90 min, the cells were transferred to 25-cm2 flasks and the medium was adjusted to a volume of 10 ml. The cultures were split and assayed for reverse transcriptase activity at the times indicated.
Reverse transcriptase assays. 
RESULTS
Construction of mutations and cloning into an simian virus 40-based expression vector. To examine the role of the leucine zipper region, a series of site-directed mutations that changed the middle isoleucine of the heptad repeat to either leucine, valine, alanine, glycine, glutamic acid, aspartic acid, or serine was constructed (Fig. 1B ). These mutant genes were then cloned into the pSRHP expression vector, a simian virus 40-derived vector that has been shown to direct a high level of envelope glycoprotein expression when transfected into COS-1 cells (7a).
Mutant glycoproteins are synthesized and processed normally. It has previously been shown for HA (17, 22) , as well as for the RSV envelope glycoprotein (10) and vesicular stomatitis virus G protein (22) , that formation of an oligomeric structure occurs posttranslationally in the rough endoplasmic reticulum. This oligomerization is essential for proper transport of the glycoprotein out of the rough endoplasmic reticulum and through the secretory pathway. Disrupting the formation of the native complex can block the transport of the glycoprotein (17, 22) . Therefore, it seemed possible that mutations within the leucine zipper-like region might affect the oligomerization of the glycoprotein and thus affect the ability to be transported normally to the cell surface. Since gpl60 cleavage takes place in the Golgi complex (43) , mutations that interfered with transport might be expected to block this processing event. To determine whether the mutations altered the ability of the glycoproteins to be transported or processed, COS-1 cells were transfected with the pSRHP vector-containing mutant and wild-type env genes. At 48 h gosttransfection, the cells were metabolically labeled with [ S] cysteine. The culture medium from a 30-min pulse-3-h chase labeling was harvested, the cells were lysed, and the cell and culture medium fractions were immunoprecipitated with serum from an HIV-infected individual. Immunoprecipitates were analyzed by SDS-PAGE and subjected to autoradiography.
Because of the labile nature of the gpl2O-gp4l interaction, gpl20 is readily shed from the cell surface. Therefore shedding of glycoprotein into the culture medium could be used to determine whether the glycoprotein had been transported to the cell surface. The gpl20 shed from the surface of cells transfected with wild-type pSRHP is evident in the culture medium ( Fig. 2A, Wt [wild type] , lane M) of these wild-type env-expressing cells. Moreover, a similar amount of released gpl20 is present in the culture media from cells transfected with each of the mutant constructs ( Fig. 2A) . When the amount of cell-associated glycoprotein was quantitated on an AMBIS radioanalytic imaging system and compared with that released into the medium, similar ratios of supernatant versus cell-associated glycoprotein were observed for all of the mutants (Fig. 2B) . The slight differences in the amount of glycoprotein released into the media were not reproducible. (Fig. 3A) . A similar pattern of surface staining can be seen in the I573V, I573G, 1573E, and I573S mutants as well (Fig. 3B, C (Fig. 4) other viral glycoproteins in these sedimentation analyses in that the glycoprotein from the pulse does not form a discrete band in the gradient but rather appears as a smear throughout the upper fractions. A pattern similar to that presented here has been reported by others (44) . A comparison of the wild type and the I573E and I573A mutants showed similar patterns of gradient sedimentation for their glycoprotein products (Fig. 4) . The same results were obtained for each of the other mutants (data not shown). These results confirm that the mutations do not affect the oligomerization of the HIV-1 glycoprotein and support the results of the metabolic labeling experiments described above.
Mutations within the leucine zipper affect the fusogenic properties of the protein. In contrast to many regions of the HIV envelope, the leucine zipper region of HIV-1 is highly conserved. In the region spanning the 29 amino acids of the leucine zipper, there are only two amino acid differences in the 11 isolates compared in Fig. 1A . This high degree of conservation argues strongly for a functional role for this sequence rather than a purely structural role whereby mutations might be more easily tolerated. To determine whether glycoproteins with mutations in this region were still functional, a HeLa-T4 fusion assay was used to test the ability of the mutant glycoproteins to induce membrane fusion of CD4-expressing cells. In this assay, the mutant genes were expressed from the pSRHP vector following transfection into HeLa cells that constitutively express CD4, the receptor for HIV-1 (24) . When the wild-type env gene is expressed in these cells, large multinucleate cells (syncytia) containing up to 50 nuclei are formed (Fig. 5A) . Syncytia containing numbers of nuclei similar to those in the wild type resulted when the I573V (Fig. SB) or I573L (data not shown) mutant env gene was expressed in HeLa-T4 cells. However, all of the mutations except the 1573A mutation resulted in the expression of glycoproteins that were unable to form syncytia when assayed in this system (Fig. SD) . The 1573A mutation was particularly interesting since it retained an intermediate phenotype that resulted in the production of a reduced number of syncytia containing only three or four nuclei (Fig. SC) .
To ensure that the proteins were being expressed at equivalent levels in these experiments, an aliquot of the transfected cells was replated onto coverslips, and internal immunofluorescence assays were performed by using a monoclonal antibody to the V3 loop region of gpl20. Diffuse internal fluorescent staining of syncytia can be seen in cells expressing the wild-type glycoprotein (Fig. 5E ). High-level expression of the HIV glycoproteins is also evident in cells transfected with expression vectors containing the mutant env genes (Fig. 5F to H) . Moreover, it can be clearly seen that following transfection with the pSRHP expression vector containing the glutamic acid mutation (1573E), cells expressing high levels of glycoprotein are in contact with neighboring cells but are not fusing with them (Fig. SH) . A more diffuse staining is seen in the cells transfected with constructs that form syncytia, presumably as a result of the diffusion of the glycoprotein product from the single cell expressing the glycoprotein to the mass of cells involved in the syncytium.
Similar data on syncytium formation were obtained when COS-1 cells, transfected with the pSRHP expression vector containing the mutant env genes, were overlayed on HeLa-T4 cells. In this more sensitive assay, the aspartic acid, glutamic acid, serine, and glycine substitutions were once again unable to induce cell-cell fusion, and the alanine substitution resulted in a significant reduction in fusion (data not shown).
Mutations in the leucine zipper region affect virus infectivity. To determine whether the defect in syncytium formation correlated with infectivity, the mutant env genes were cloned into the infectious molecular HIV-1 clone pHXB2Dgpt (12) . COS-1 cells were transfected with the mutant constructs, and 48 h posttransfection, the supernatants were harvested and assayed for reverse transcriptase activity. Concurrently, the cells were labeled with [35S]methionine, immunoprecipitated with serum from an HIV-1-infected individual, and analyzed by SDS-PAGE. Similar patterns of protein expression were seen for all of the constructs, and normal processing of the glycoprotein precursors was observed (Fig. 6 ). This result again confirmed that the mutations did not affect the ability of the glycoprotein to be synthesized, transported, or processed. Aliquots of the supernatants from the transfected COS-1 cells were adjusted to contain equal amounts of reverse transcriptase activity and were used to infect H9 cells to assay for infectivity. At 4-to 5-day intervals, the cells were split and aliquots of the culture medium were removed for reverse transcriptase analysis. Infection with the wild-type virus resulted in the rapid accumulation of high levels of reverse transcriptase in the culture medium (Fig. 7) , and large HeLa-T4 cells were transfected with the pSRHP expression vector by using the DEAE-dextran technique. Two days after transfection, the cells were stained for syncytia (A to D) or fixed with 95% ethanol-5% acetic acid and stained by using a monoclonal antibody specific for the V3 loop of gp120 (E to H) as described in syncytia were observed in the culture (data not shown), indicating efficient spread of virus infection from cell to cell. A similar rate of infection was seen for the 1573L and 1573V mutants, with a corresponding production of reverse transcriptase. All of the other mutant viruses except I573A failed to produce detectable signs of infection, with neither reverse transcriptase activity nor syncytia being detectable. The 1573A mutant produced a slowly spreading infection that showed an increase in reverse transcriptase activity at day 12 that peaked at day 18 at a level approximately fivefold lower than that of the wild type.
The infectivity results paralleled the results of syncytiumforming assays on HeLa-T4 cells. Moreover, the slow spread of infection observed for the 1573A mutant correlated with the small syncytia produced in the HeLa-T4 assay. The observation that even relatively conservative mutations (i.e., I573A) in the leucine zipper region could interfere or block the ability of the virus to infect cells is striking and points to an important role for this region in a post-CD4 binding step.
DISCUSSION
The identification of a leucine zipper repeat in the TM proteins of the HIVs as well as many other viruses led to the hypothesis that this region may be involved with the oligomerization of these proteins in a manner similar to that which occurs with DNA-binding proteins. normally and transported to the cell surface. The env gene product of RSV continues to form oligomers after the membrane anchor domain and cytoplasmic domains have been deleted, although these oligomeric complexes appear to be less stable than the wild-type glycoprotein (10) . When the transmembrane and cytoplasmic domains of vesicular stomatitis virus (5), RSV (9), or HIV (36) are replaced by a glycophospholipid anchor, the proteins oligomerize normally and are efficiently transported. Moreover, when the TM protein of RSV is expressed in the absence of the SU domain, the glycoprotein rapidly oligomerizes after translation (9) . The hypothesis that the leucine zipper may play a role in oligomerization has been supported by the fact that these repeats occur in a region of the protein that is predicted to be an extended alpha helix and because they are in a location similar to that of the region of the HA2 molecule known to be responsible for stabilizing the HA oligomeric structure (16) . The latter interaction is stabilized by the hydrophobic surface interaction of the alpha helices (47) . Although the exact process of oligomerization is not understood, we hypothesized that interrupting this region with charged residues would disrupt the interacting hydrophobic faces and interfere with the ability of the glycoproteins to oligomerize normally. Surprisingly, this was not the result that we observed. Even mutant glycoproteins in which the hydrophobic isoleucine was substituted by a charged glutamic or aspartic acid appeared to oligomerize normally and were transported to the plasma membrane with kinetics similar to those of the wild-type glycoprotein. Thus, the mutations do not alter any structural features necessary for oligomer formation sufficiently to disrupt transport or oligomerization.
While the leucine zipper repeats of the HIV-1 glycoprotein have one or more isoleucine residues in place of leucine residues, the basic features of a leucine zipper remain. In addition to mutational analyses showing that an isoleucine can be substituted for leucine residues with little or no effect (20) , many of the proteins generally thought to contain leucine zippers also have substitution of the leucine residues (20, 23 (13, 18, 19, 21, 45, 46) ; however, in each of these cases, the basis of the defect is less clear. The I573A mutant will be particularly useful for the selection of pseudorevertants that might give additional insights into intramolecular interactions and to the role of this region in glycoprotein function.
Although the changes in the leucine zipper do not abrogate the ability of the gpl60 molecules to oligomerize, they may still affect interactions between the monomers that are required for conformational changes to occur following the binding of receptor. Many viral glycoproteins undergo an acid-induced conformational change that is required for the molecule to initiate membrane fusion. The best-understood example of this is the HA of influenza virus, which in the acidic compartment of the endosome undergoes a conformational change which exposes the hydrophobic fusion peptide (reviewed in reference 41). Daniels et al. demonstrated that amino acid changes within the interface between HA2 monomers could result in HA proteins that were able to induce cell fusion at higher pHs, presumably through a destabilization of the trimer structure (6) . An analogous, though opposite, result was recently reported for the S2 glycoprotein of mouse hepatitis virus type 4. In this case, a natural variant of this membrane-spanning glycoprotein was unable to induce cell fusion at neutral pH (typical of the wild type) but could at acidic pH (14) . The pH dependence of the variant S2 glycoprotein was localized to three mutations in a leucine zipper-like heptad repeat which has been postulated to stabilize the trimer structure of the S glycoprotein complex. Thus, changes within regions known or postulated to mediate oligomer interactions have been shown to alter the requirements for membrane fusion for two proteins analogous to HIV-1 gp4l. Although the events leading to virusinduced fusion by HIV-1 are poorly understood, it is known that fusion occurs through a pH-independent mechanism (25, 27) and that conformational changes occur following CD4 binding (37) . Presumably, these conformational changes result in a fusion-competent glycoprotein complex that can initiate fusion of the viral and host cell membranes. The mutant glycoproteins that we have described here, which have been shown to bind CD4 (data not shown), may be unable to undergo the necessary conformational changes and are thus defective in initiating the process of membrane fusion. It is interesting to note that a variant of HIV-1/HXB2 that was resistant to neutralization by patient serum contained a single alanine-to-threonine change within the last heptad of the leucine zipper (35) . Thus, changes in this region may have significant effects on the tertiary structure of the HIV glycoprotein. Preliminary experiments using media with a range of pHs from 5.5 to 8.0 have failed to detect any changes in the pH dependence of syncytium formation or any activation of fusion at pHs other than that of culture medium (data not shown).
It is also possible that the leucine zipper region of the HIV-1 TM protein is involved in interactions with components in the target cell membrane. Qureshi et al. (32) have reported on a putative membrane receptor for the HIV TM protein, using peptides that encompass the last heptad of the leucine zipper. Thus, it is possible that the changes that we have introduced into this region interfere with such interactions. Experiments aimed at determining whether mutant gp4l proteins can no longer bind the putative receptor should provide insights into this possibility.
